Literature DB >> 7392568

Impairment of phagocytosis by moderate hyperoxia (40 to 60 per cent oxygen) in lung macrophages.

T A Raffin, L M Simon, D Braun, J Theodore, E D Robin.   

Abstract

Exposure of isolated mouse lung macrophages to 40 and 60 per cent oxygen in tissue culture for 48 hours resulted in significant depression of phagocytosis as compared to air-exposed controls. The impairment of phagocytosis was reversed when the cells were reexposed to normoxic conditions for 48 hours. The impairment of phagocytosis occurred despite significant increases in intracellular superoxide dismutase activity, an enzyme felt to play a protective role in oxygen toxicity. Exposure to 40 and 60 per cent oxygen increased the susceptibility of lung macrophages to functional impairment by 95 per cent oxygen, rather than producing tolerance. The precise biologic and clinical significance of these findings will require additional studies in integrated systems. However, these studies show unequivocal lung macrophage injury with moderate hyperoxic exposure.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7392568

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  12 in total

1.  Hyperoxia, HMGB1, and ventilator-associated pneumonia: reducing risk by practicing what we teach.

Authors:  Thomas P Kennedy; Steve Nelson
Journal:  Am J Respir Cell Mol Biol       Date:  2013-03       Impact factor: 6.914

Review 2.  Antioxidants in neonatal lung disease.

Authors:  C H Fardy; M Silverman
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-09       Impact factor: 5.747

3.  Innate immunity against bacterial infection following hyperoxia exposure is impaired in NRF2-deficient mice.

Authors:  Narsa M Reddy; Vegiraju Suryanarayana; Dhananjaya V Kalvakolanu; Masayuki Yamamoto; Thomas W Kensler; Paul M Hassoun; Steven R Kleeberger; Sekhar P Reddy
Journal:  J Immunol       Date:  2009-09-04       Impact factor: 5.422

Review 4.  Relationship between hyperoxemia and ventilator associated pneumonia.

Authors:  Karim Jaffal; Sophie Six; Farid Zerimech; Saad Nseir
Journal:  Ann Transl Med       Date:  2017-11

5.  Ascorbic Acid Attenuates Hyperoxia-Compromised Host Defense against Pulmonary Bacterial Infection.

Authors:  Vivek S Patel; Vaishali Sampat; Michael Graham Espey; Ravikumar Sitapara; Haichao Wang; Xiaojing Yang; Charles R Ashby; Douglas D Thomas; Lin L Mantell
Journal:  Am J Respir Cell Mol Biol       Date:  2016-10       Impact factor: 6.914

6.  Lung cell oxidant injury. Enhancement of polymorphonuclear leukocyte-mediated cytotoxicity in lung cells exposed to sustained in vitro hyperoxia.

Authors:  N Suttorp; L M Simon
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

7.  Antioxidants preserve macrophage phagocytosis of Pseudomonas aeruginosa during hyperoxia.

Authors:  Dympna M P Morrow; Tahereh Entezari-Zaher; John Romashko; Ali O Azghani; Mohammad Javdan; Luis Ulloa; Edmund J Miller; Lin L Mantell
Journal:  Free Radic Biol Med       Date:  2007-01-23       Impact factor: 7.376

8.  Oxidant injury of lung parenchymal cells.

Authors:  W J Martin; J E Gadek; G W Hunninghake; R G Crystal
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

9.  The α7 nicotinic acetylcholine receptor agonist GTS-21 improves bacterial clearance in mice by restoring hyperoxia-compromised macrophage function.

Authors:  Ravikumar A Sitapara; Daniel J Antoine; Lokesh Sharma; Vivek S Patel; Charles R Ashby; Samir Gorasiya; Huan Yang; Michelle Zur; Lin L Mantell
Journal:  Mol Med       Date:  2014-06-19       Impact factor: 6.354

10.  Impact of hyperoxemia on mortality in critically ill patients with ventilator-associated pneumonia.

Authors:  Sophie Six; Anahita Rouzé; Olivier Pouly; Julien Poissy; Frédéric Wallet; Sébastien Preau; Saad Nseir
Journal:  Ann Transl Med       Date:  2018-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.